⌘K
Loading ticker…
CVS HEALTH CORPORATION · Consumer Discretionary · Retail
As of 2026-06-26, CVS HEALTH CORPORATION (CVS) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47 (Neutral). Sector: Consumer Discretionary, ranked 10 of 11. Average daily range 2.5%, relative volume 1.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 88, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CVS is in a stage 2 uptrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 14.4% / 28.9%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CVS is held by 16 ETFs as of Mar 2026. Top owner: VTI at 0.15% weight, $2.9B notional. Top 3 carry $6.4B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.15% | $2.9B |
| VOOVanguard S&P 500 ETF | 0.16% | $2.3B |
| IVViShares Core S&P 500 ETF | 0.16% | $1.2B |
| SPYState Street SPDR S&P 500 ETF | 0.16% | $1.1B |
| VTVVanguard Value ETF | 0.37% | $845M |
| XLVState Street Health Care Select Sector SPDR ETF | 1.72% | $665M |
| IWDiShares Russell 1000 Value ETF | 0.30% | $207M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.16% | $192M |
| IVEiShares S&P 500 Value ETF | 0.34% | $158M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.14% | $115M |
Showing 10 of 16 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CVS Jan avg: 2.14% median: -5.57% win: 25% σ: 15.79% n: 4 2022-04-12 → 2026-05-29 | CVS Feb avg: 4.57% median: 3.61% win: 75% σ: 9.39% n: 4 2022-04-12 → 2026-05-29 | CVS Mar avg: -2.71% median: -3.51% win: 50% σ: 9.26% n: 4 2022-04-12 → 2026-05-29 | CVS Apr avg: -2.00% median: -1.54% win: 20% σ: 11.52% n: 5 2022-04-12 → 2026-05-29 | CVS May avg: -2.66% median: -4.00% win: 40% σ: 8.09% n: 5 2022-04-12 → 2026-05-29 | CVS Jun avg: 1.05% median: 0.36% win: 50% σ: 5.05% n: 4 2022-04-12 → 2026-05-29 (current) | CVS Jul avg: 0.87% median: 2.71% win: 75% σ: 7.67% n: 4 2022-04-12 → 2026-05-29 | CVS Aug avg: 0.63% median: -1.27% win: 50% σ: 13.04% n: 4 2022-04-12 → 2026-05-29 | CVS Sep avg: 4.30% median: 5.10% win: 75% σ: 5.52% n: 4 2022-04-12 → 2026-05-29 | CVS Oct avg: -2.10% median: -0.93% win: 25% σ: 5.83% n: 4 2022-04-12 → 2026-05-29 | CVS Nov avg: 3.72% median: 4.42% win: 75% σ: 4.02% n: 4 2022-04-12 → 2026-05-29 | CVS Dec avg: -4.64% median: -4.89% win: 25% σ: 17.08% n: 4 2022-04-12 → 2026-05-29 |